Versant Venture Capital III, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital III, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital III, L.P.. Versant Venture Capital III, L.P. is 10% Owner in Trius Therapeutics Inc ($TSRX) and 10% Owner in OCULAR THERAPEUTIX, INC ($OCUL).
Latest Insider Trading Transactions of Versant Venture Capital III, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 1,878 | 41,316 | 13,007 | 14.9 K to 13 K (-12.62 %) |
| Jun 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 318,122 | 6,998,684 | 2,202,377 | 2.5 M to 2.2 M (-12.62 %) |
| Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 2,506 | 55,132 | 14,885 | 17.4 K to 14.9 K (-14.41 %) |
| Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 424,494 | 9,338,868 | 2,520,499 | 2.9 M to 2.5 M (-14.41 %) |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 4,469,697 | 0 | 0 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 9,090,910 | 0 | 0 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Buy | P | 5.00 | 914,529 | 4,572,645 | 3,235,839 | 2.3 M to 3.2 M (+39.40 %) |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 4.38 | 744,496 | 3,260,892 | 2,321,310 | 1.6 M to 2.3 M (+47.22 %) |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 1,576,814 | 0 | 1,576,814 | 0 to 1.6 M |
Page: 1